Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

In follicular lymphoma (FL), progression of disease ≤24 months (POD24) has emerged as an important prognostic marker for overall survival (OS). We aimed to investigate survival more broadly by timing of progression and treatment in a national population-based setting. We identified 948 stage II-IV i...

Full description

Bibliographic Details

Published in:	HemaSphere
Main Authors:	Caroline E. Weibull, Tove Wästerlid, Björn Engelbrekt Wahlin, Per-Ola Andersson, Sara Ekberg, Sandra Lockmer, Gunilla Enblad, Michael J. Crowther, Eva Kimby, Karin E. Smedby
Format:	Article
Language:	English
Published:	Wiley 2023-03-01
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000838